Inventprise
is a Private company. Yves Leurquin is the CEO of Inventprise. Inventprise has raised a total of $90.3M in funding. Inventprise has 2 followers on Owler.Inventprise
is a Private company. Yves Leurquin is the CEO of Inventprise. Inventprise has raised a total of $90.3M in funding. Inventprise has 2 followers on Owler.
News
Nov 04, 2025
Yahoo
Inventprise: Redmond-based vaccine company laying off over 70 workers
Nov 01, 2025
Geekwire
Inventprise: Filing: Seattle-area vaccine company Inventprise laying off 76 employees
Jun 24, 2025
Benzinga
Inventprise: Inventprise Announces Breakthrough in COVID-19 Conjugate Vaccine Study Published in Vaccine Journal
May 15, 2025
Manufacturing Chemist
Inventprise: Inventprise selects Quantoom's production technology to advance mRNA vaccine development
Jan 01, 2024
Acrofan
Inventprise: Inventprise Completes Vaccination of Participants in a Phase 2 Dose Ranging Study of its 25 Valent Pneumococcal Vaccine Candidate
Nov 09, 2022
Acrofan
Inventprise: New Inventprise Pneumococcal Vaccine Enters Phase 1/2 Clinical Evaluation
May 10, 2022
BioPharma-Reporter
Inventprise: Inventprise inaugurates manufacturing facility for pneumococcal conjugate vaccines
Nov 12, 2021
Philanthropy News Digest
Inventprise: Gates Foundation to invest up to $90 million in pneumococcal vaccine
Nov 10, 2021
The Business Journals: Seattle
Inventprise: Gates Foundation to invest up to $90M in vaccine maker Inventprise
Nov 10, 2021
Endpoints News
Inventprise: Bill and Melinda Gates Foundation backs little-known biotech going after Pfizer, Merck on pneumococcal vaccine